February 5, 2020 PR-M02-20-NI-009
Pharma’s Almanac has entered into a media partnership with the Yale Innovation Summit, presented by Yale’s Office of Cooperative Research (OCR). Through the partnership, Pharma’s Almanac will to bring attention to the event and distribute information about the Yale Innovation Summit to decision makers in the pharmaceutical industry.
“This is a great opportunity to partner with an event that aligns with our publication,” stated David Alvaro, Ph.D., Editor in Chief of Pharma’s Almanac. “We look forward to promoting the Yale Innovation Summit in Pharma’s Almanac, both in print and digitally. We are also eager to attend the event, interview key speakers, and highlight their work in future issues,” he continued.
Readers of Pharma’s Almanac are encouraged to attend the summit and take advantage of a discounted rate by using the code: PharmasA25.
The Yale Innovation Summit takes place on May 13, 2020. The summit will feature two keynote speakers, 16 faculty pitches, 20 company presentations, over 35 panelists. and more than 100 e-posters. The summit will be followed by a reception, co-hosted with the City of New Haven and BioCT, at Temple Plaza in downtown New Haven. By bringing together entrepreneurially minded faculty and other members of the community with potential investors and other stakeholders, the summit hopes to connect people and lay the groundwork for more start-ups seeking to spin technology out of Yale. For the first time ever, the summit will feature a Career Expo aimed at bringing local companies together with talent.
Susan Hockfield will be the event’s first Keynote speaker, during the morning session. A noted neuroscientist, Hockfield was the first life scientist and the first woman to serve as President of the Massachusetts Institute of Technology, from 2004 to 2012. Previously, she held the positions of Provost and Dean of the Graduate School of Arts and Sciences while she was the William Edward Gilbert Professor of Neurobiology at Yale University.
Katie Rae will deliver the afternoon’s Keynote. She serves as the CEO and Managing General Partner of The Engine, and is also co-founder and Managing Director of Project 11 Ventures. She serves as a Board Member at Commonwealth Fusion Systems, Form Energy, Via Separations, and Boston Metal. She has advised hundreds of founders and invested in nearly 100 companies at the earliest stages of formation.
“I’m looking forward to the Yale Innovation Summit and its display of frontier-breaking innovations that tackle some of the planet’s most pressing problems,” commented Susan Hockfield, Ph.D., President Emerita at Massachusetts Institute of Technology. “The accelerating pace of new, boundary-crossing technologies inspires my confidence in a future that will be better than the present. I’m immensely honored to return to Yale as one of the Summit's Keynote speakers,” she continued.
“OCR plans to have a reception at the plaza across from the Omni New Haven Hotel at Yale to make that announcement and “celebrate all the economic impact that is happening locally,” added Jon Soderstrom, Managing Director of Yale OCR.
Applications are being accepted through March 31st, 2020. For more information on the summit, please visit https://yaleinnovationsummit.com/.
Pharma’s Almanac’s first-quarter Executive Issue goes live on March 16, 2020, and will be available in full digitally. If you would like to have Pharma’s Almanac delivered to you, please contact firstname.lastname@example.org. For more information, please visit https://www.pharmasalmanac.com/.
About Pharma’s Almanac
Since its inception in 2015, Pharma’s Almanac, a Nice Insight publication, has grown into a leading source for thought leadership. Pharma's Almanac covers the industry's most intensive markets, active business sectors, and major players. Pharma’s Almanac is a go-to resource for industry happenings, from in-depth analysis of pharma/biotech research and discovery to manufacturing, the supply chain, and future tech, as well as daily press releases and weekly news stories. To view all issues and view the media kit, please visit https://www.pharmasalmanac.com/.
For more information contact:
Yale University Office of Cooperative Research
Office of Cooperative Research
David Alvaro, PhD
Scientific Editor in Chief and Research Director
Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.
Since its founding in 1982, the Yale Office of Cooperative Research (OCR) has built a significant portfolio of inventions and patents and has grown into an engine of regional economic development. Its mission is to facilitate the translation of research from Yale’s labs into products and services that benefit society. OCR is recognized as a leading force for catalyzing economic growth by identifying, counseling and nurturing early-stage technologies and guiding the transition into robust companies.